(Reuters) - Advisers to the U.S. Food and Drug Administration on Tuesday recommended the authorization of Moderna Inc's COVID-19 vaccine for children and teens aged 6 to 17 years of age.
(Reuters) – Advisers to the U.S. Food and Drug Administration on Tuesday recommended the authorization of Moderna Inc’s COVID-19 vaccine for children and teens aged 6 to 17 years of age.
(Reporting by Manas Mishra in Bengaluru; Editing by Chris Reese)
Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products:
